Background
==========

Symptomatic severe aortic stenosis (AS) is the third most common cause of heart disease after hypertension and coronary artery disease in developed countries. AS generally presents with exertional dyspnea, syncope, and exertional chest pain \[[@b1-amjcaserep-19-739]\]. Severe AS is normally defined by a combination of an aortic valve (AV) area ≤1 cm^2^ and a mean transvalvular pressure gradient ≥40 mmHg \[[@b2-amjcaserep-19-739]\]. However, some patients have a gradient less than 40 mmHg, left ventricle (LV) stroke volume index ≤35 mL/m^2^ with a AV area under 1.0 cm^2^. This low-flow, low-gradient (LFLG) severe AS is difficult to detect and requires a high index of suspicion. It is further classified into classical LFLG-AS in which there is reduced LV ejection fraction (LVEF) and paradoxical LFLG-AS associated with preserved EF \[[@b3-amjcaserep-19-739]\]. Echocardiogram is used for the diagnosis of LFLG-AS and it is confirmed with cardiac catheterization. Transcatheter aortic valve replacement (TAVR) is currently recommended for patients with true AS with moderate to high risk according to Society of Thoracic Surgery (STS) risk score.

Transudative pleural effusions according to Light's Criteria is defined as a ratio of pleural fluid protein to serum protein \<0.5 and a pleural fluid lactate dehydrogenase (LDH) to serum LDH ratio \<0.6. Caused by either increased hydrostatic pressure, such as in heart failure, or decreased oncotic pressure, such as in liver cirrhosis or nephrotic syndrome \[[@b4-amjcaserep-19-739]\].

Case Report
===========

An 86-year-old non-smoking female with mild chronic obstructive pulmonary disease presented for recurrent exertional dyspnea secondary to pleural effusion to our cardiology clinic. She had a 2-year history of recurrent, right-sided pleural effusion with multiple thoracentesis procedures and was being considered for a pleurodesis.

On physical examination, she was found to be hypoxic, have diminished breath sounds, dullness to percussion on the right side with no crackles or wheezes detected, a grade of 4/6 ejection systolic murmur at the right upper sternal border with an absent A2 component and delayed carotid upstroke. The neck examination was negative for jugular venous distension.

Chest x-ray showed right-sided pleural effusion before the TAVR procedure ([Figure 1](#f1-amjcaserep-19-739){ref-type="fig"}). Thorax computed topography (CT) showed a moderate right pleural effusion before AV intervention ([Figure 2](#f2-amjcaserep-19-739){ref-type="fig"}). Laboratory results showed no leukocytosis, no coagulopathy, no hypoalbuminemia, normal platelet counts, normal thyroid function test, and the B natriuretic peptide (BNP) result was lower than 100 excluding cardiac etiology. QuantiFERONTB Gold test for tuberculosis was negative ([Table 1](#t1-amjcaserep-19-739){ref-type="table"}).

A thoracentesis was consistent with transudative pleural effusion with the pleural fluid protein to serum protein of 0.42, and the pleural fluid lactate dehydrogenase (LDH) to serum LDH ratio of 0.27. The results were negative for gram stain, fungal culture, and acid-fast bacilli stain and culture. Pathology reports showed no malignant cells were identified ([Table 2](#t2-amjcaserep-19-739){ref-type="table"}).

The echocardiogram showed normal LV size, wall thickness, and systolic function; grade II diastolic dysfunction and EF 75%. It showed moderate dilated left atrium with left atrial volume index of 46 mL/m^2^ and moderate calcific severe AS. The AV area was 0.67 cm^2^, AV mean gradient was 34 mmHg, with peak at 49 mmHg. The LV stroke volume index was below 35 mL/m^2^. The right atrial size was normal; the right atrial pressure was estimated to be 3 mmHg. There was normal right ventricular size and systolic function. The right ventricular systolic pressure was estimated to be 45 mmHg ([Figures 3](#f3-amjcaserep-19-739){ref-type="fig"}[](#f4-amjcaserep-19-739){ref-type="fig"}--[5](#f5-amjcaserep-19-739){ref-type="fig"}).

The right heart catherization showed right atrium was 8 mmHg, right ventricle was 45/10/13 mmHg, pulmonary artery was 45/25 (30) mmHg, and pulmonary wedge was 13 mmHg. Cardiac output per thermal dilution was 4.77. Cardiac index per thermal dilution was 2.52.

Left side heart catherization showed moderate to severe AS with peak to peak gradient 35 mmHg, mean gradient 35 mmHg, calculated AV area 0.61 cm^2^, nonobstructive coronary artery disease, EF 65%, mildly dilated ascending aorta, moderate caliber distal aorta with 30% eccentric stenosis on right lateral wall, and normal appearing bilateral ilio-femoral arteries.

Discussion
==========

AS is generally asymptomatic until stenosis is severe enough to cause symptoms. Classical symptoms are angina, syncope, heart failure, and sudden death \[[@b5-amjcaserep-19-739]\]. During the evaluation of patients with severe AS, it is important to distinguish between true stenosis or pseudo stenosis as it affects the patient management plan. Dobutamine stress echocardiography, invasive valve study, or multidetector CT can be used to confirm severe stenosis when AV calcium score is \>1200 AU in a female or \>2000 AU in a male \[[@b6-amjcaserep-19-739]\].

Patients with STS moderate- to high-risk AV stenosis have a high perioperative and postoperative mortality.

Pleural effusions can be seen in many conditions, including those with left-sided heart failure secondary to increased hydrostatic pressure, and it is generally present with bilateral pleural effusion with variation depending on which side is more prominent. However, unilateral pleural effusion secondary to severe AS in the absence of heart failure is unusual. Here, in a patient 86-year-old female with no significant lung disease, and severe low gradient flow AS.

The diagnosis was made after excluding of all other causes of pleural effusion mentioned in the table above and confirmed by lack of symptoms during follow-up visits on a regular basis with a series of chest x-rays and echocardiograms to ensure resolving effusion after the TAVR procedure ([Figure 6](#f6-amjcaserep-19-739){ref-type="fig"}).

Conclusions
===========

Pleural effusions can be seen in patients with severe AS complicated with hemodynamic significant heart failure and are generally present as bilateral pleural effusion. Unilateral pleural effusion is an unusual presentation, making this case an important example of how LFLG-AS can present with unilateral effusion even with the lack of significant manifestation of heart failure in a patient with mild diastolic dysfunction. The mechanism was likely due to diastolic dysfunction and increased hydrostatic pressure.

**Conflict of interests**

None.

![Chest x-ray showed right-sided pleural effusion before transcatheter aortic valve replacement procedure.](amjcaserep-19-739-g001){#f1-amjcaserep-19-739}

![Computed topography scan thorax reveals moderate right pleural effusion before aortic valve intervention.](amjcaserep-19-739-g002){#f2-amjcaserep-19-739}

![Parasternal long axis view shows calcified aortic valve leaflets.](amjcaserep-19-739-g003){#f3-amjcaserep-19-739}

![Continuous wave Doppler recording from apical 5-chamber view showing transvalvular peak jet velocity (3.49 m/s) and pressure gradients (mean gradient=33.89 mmHg) correspond to severe low gradient aortic valve stenosis.](amjcaserep-19-739-g004){#f4-amjcaserep-19-739}

![(A, B) Diastolic function.](amjcaserep-19-739-g005){#f5-amjcaserep-19-739}

![Chest x-ray 1 month after transcatheter aortic valve replacement procedure reveal improvement in the right-sided effusion compared with before procedure.](amjcaserep-19-739-g006){#f6-amjcaserep-19-739}

###### 

Laboratory values.

  **Component**              **Value**       **Ref range and units**
  -------------------------- --------------- -------------------------
  WBC                        10.4            4.8--10.8 K/uL
  RBC                        4.32            4.20--5.40 M/uL
  Hemoglobin                 13.3            12.0--16.0 g/dL
  Hematocrit                 39.2            37.0--47.0%
  MCV                        90.7            81.4--97.8 fL
  RDW                        42.5            35.9--50.0 fL
  Platelet count             235             164--446 K/uL
  Sodium                     138             135--145 mmol/L
  Potassium                  3.8             3.6--5.5 mmol/L
  Chloride                   105             96--112 mmol/L
  Co2                        24              20--33 mmol/L
  Anion gap                  9.0             0.0--11.9
  Glucose                    117             65--99 mg/dL
  Bun                        22              8--22 mg/dL
  Creatinine                 0.85            0.50--1.40 mg/dL
  Calcium                    9.0             8.5--10.5 mg/dL
  AST (SGOT)                 17              12--45 U/L
  ALT (SGPT)                 6               2--50 U/L
  Alkaline phosphatase       88              30--99 U/L
  Total bilirubin            0.4             0.1--1.5 mg/dL
  Albumin                    3.5             3.2--4.9 g/dL
  Total protein              7.1             6.0--8.2 g/dL
  Globulin                   3.1             1.9--3.5 g/dL
  LDH total                  242             107--266 U/L
  B natriuretic peptide      69              0--100 pg/mL
  PT                         13.4            12.0--14.6 sec
  INR                        0.99            0.87--1.13
  TSH                        0.800           0.350--5.500 uIU/mL
  Carcinoembryonic antigen   1.4             0.0--3.0 ng/mL
  Ca 19-9                    19.7            0.0--35.0 U/mL
  Ca 125                     34.7            0.0--35.0 U/mL
  Sed rate Westergren        28              0--30 mm/hour
  Antinuclear antibody       None detected   None detected
  Rheumatoid factor          \<10            0--14 IU/mL

###### 

Pathology reports.

  **Pleural fluid**          **Results**
  -------------------------- -----------------
  Color: body fluid          Yellow
  Character: body fluid      Hazy
  Total RBC count            \<2000 cells/uL
  Total WBC                  231 cells/uL
  Polys                      1%
  Lymphs                     78%
  Mononuclear cells          9%
  Mesothelial cells -- CSF   2%
  Fluid histiocyte           9%
  Eosinophils -- CSF         1%
  PH                         8
  Total protein fluid        3.0
  Body fluid LDH             66
  Glucose, fluid             122
  Body fluid amylase         27
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